Value of human cartilage glycoprotein-39 and N-terminal prohormone of brain natriuretic peptide in coronary artery injury in children with Kawasaki disease

MIN Li; WANG Jin; DONG Xiangyu

doi:10.7619/jcmp.20233640

Journal of Clinical Medicine in Practice > 2024 > 28(3): 1-5. > DOI: 10.7619/jcmp.20233640

MIN Li, WANG Jin, DONG Xiangyu. Value of human cartilage glycoprotein-39 and N-terminal prohormone of brain natriuretic peptide in coronary artery injury in children with Kawasaki disease[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 1-5. DOI: 10.7619/jcmp.20233640

Citation:

PDF (729 KB)

Value of human cartilage glycoprotein-39 and N-terminal prohormone of brain natriuretic peptide in coronary artery injury in children with Kawasaki disease

Pediatric Cardiovascular Department, the Second Hospital of Lanzhou University, Lanzhou, Gansu, 730030

More Information

Received Date: November 13, 2023
Revised Date: January 15, 2024
Available Online: February 29, 2024

Graphical Abstract

Abstract

Abstract

Objective
To investigate the clinical application value of human cartilage glycoprotein-39 (YKL-40) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) in coronary artery injury (CAL) children with Kawasaki disease (KD).
Methods
A total of 125 children with KD were selected as study subjects (KD group), and divided into CAL group (n=53) and no coronary artery injury (NCAL) group (n=72) according to whether they were complicated with coronary artery disease. Healthy children who underwent physical examination during the same period (HC group) and only the digestive tract infection of children with fever in the same period (FC group) in the hospital were selected as control. Plasma levels of YKL-40 and NT-proBNP were measured. Receiver operating characteristic (ROC) curve was drawn to evaluate the diagnostic value of YKL-40 and NT-proBNP in CAL at different periods of KD children.
Results
Plasma YKL-40 and NT-proBNP levels in KD children were significantly higher than those in the HC group and the FC group at different periods (acute stage, subacute stage and recovery stage) (P < 0.05). YKL-40 level in the CAL group was significantly higher than that in the NCAL group, and NT-proBNP in acute stage was significantly higher than that in the NCAL group (P < 0.05). The area under the curve (AUC) of YKL-40, NT-proBNP and their combination in diagnosing CAL in acute period of KD were 0.813, 0.832 and 0.886, respectively; the AUC of YKL-40, NT-proBNP and their combination in the diagnosis of KD subacute CAL were 0.699, 0.522 and 0.701, respectively; the AUC of YKL-40, NT-proBNP and their combination in diagnosing coronary artery injury during KD convalesce were 0.982, 0.435 and 0.986, respectively.
Conclusion
Plasma YKL-40 and NT-proBNP levels can be used as early diagnostic indicators for KD. Plasma YKL-40 can be used in combination with other indicators to monitor KD disease activity and the development of complications from coronary artery injury.

FullText(HTML)

References (33)

References

[1]	MCCRINDLE B W, ROWLEY A H, NEWBURGER J W, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American heart association[J]. Circulation, 2017, 135(17): e927-e999.
[2]	PILANIA R K, JINDAL A K, BHATTARAI D, et al. Cardiovascular involvement in Kawasaki disease is much more than mere coronary arteritis[J]. Front Pediatr, 2020, 8: 526969. doi: 10.3389/fped.2020.526969
[3]	李奇蕊, 林利, 王勤, 等. 川崎病伴巨大冠状动脉瘤及血栓致猝死一例[J]. 中国小儿急救医学, 2019, 26(4): 319-320. doi: 10.3760/cma.j.issn.1673-4912.2019.04.019
[4]	FUKAZAWA R, KOBAYASHI J, AYUSAWA M, et al. JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease[J]. Circ J, 2020, 84(8): 1348-1407. doi: 10.1253/circj.CJ-19-1094
[5]	SCHRAUBEN S J, SHOU H C, ZHANG X M, et al. Association of multiple plasma biomarker concentrations with progression of prevalent diabetic kidney disease: findings from the chronic renal insufficiency cohort (CRIC) study[J]. J Am Soc Nephrol, 2021, 32(1): 115-126. doi: 10.1681/ASN.2020040487
[6]	XING Y, GUO J T, GAI L Y, et al. Serum YKL-40 is associated with the severity of coronary artery disease and hypertension[J]. Asian J Surg, 2020, 43(11): 1121-1122. doi: 10.1016/j.asjsur.2020.08.016
[7]	江载芳, 申昆玲, 沈颖. 诸福棠实用儿科学[M]. 8版. 北京: 人民卫生出版社, 2015: 780-781.
[8]	FUKAZAWA R, IKEGAM E, WATANABE M, et al. Coronary artery aneurysm induced by Kawasaki disease in children show features typical senescence[J]. Circ J, 2007, 71(5): 709-715. doi: 10.1253/circj.71.709
[9]	杨轶男, 闵丽, 董湘玉, 等. 川崎病并发冠状动脉病变引发成年后不稳定性心绞痛1例报告并文献复习[J]. 临床儿科杂志, 2020, 38(7): 493-496. doi: 10.3969/j.issn.1000-3606.2020.07.004
[10]	RAMOS-ESPINOSA G, WANG Y Y, BRANDNER J M, et al. Melanoma associated chitinase 3-like 1 promoted endothelial cell activation and immune cell recruitment[J]. Int J Mol Sci, 2021, 22(8): 3912. doi: 10.3390/ijms22083912
[11]	JIAO Y G, QIN Y H, ZHANG Z G, et al. Early identification of carotid vulnerable plaque in asymptomatic patients[J]. BMC Cardiovasc Disord, 2020, 20(1): 429. doi: 10.1186/s12872-020-01709-5
[12]	PENG J N, YU Q, FAN S L, et al. High blood eosinophil and YKL-40 levels, as well as low CXCL9 levels, are associated with increased readmission in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2021, 16: 795-806. doi: 10.2147/COPD.S294968
[13]	FOLKERSEN L, GUSTAFSSON S, WANG Q, et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30, 931 individuals[J]. Nat Metab, 2020, 2(10): 1135-1148. doi: 10.1038/s42255-020-00287-2
[14]	JUNG Y Y, KIM K C, PARK M H, et al. Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice[J]. Theranostics, 2018, 8(3): 749-766. doi: 10.7150/thno.20183
[15]	WALLENTIN L, ERIKSSON N, OLSZOWKA M, et al. Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: a retrospective study[J]. PLoS Med, 2021, 18(1): e1003513. doi: 10.1371/journal.pmed.1003513
[16]	KJAERGAARD A D, JOHANSEN J S, BOJESEN S E, et al. Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases[J]. Crit Rev Clin Lab Sci, 2016, 53(6): 396-408. doi: 10.1080/10408363.2016.1190683
[17]	KIM K Y, AHN Y, KIM D Y, et al. Elevated serum YKL-40 levels in patients with Kawasaki disease[J]. Biomarkers, 2017, 22(3/4): 326-330.
[18]	孙东明, 许渝, 张丽萍, 等. 川崎病患儿血清YKL-40的变化及与冠状动脉病变之间的关系[J]. 临床心血管病杂志, 2017, 33(4): 328-330. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB201704008.htm
[19]	ZHU F, ANG J Y. 2021 update on the clinical management and diagnosis of Kawasaki disease[J]. Curr Infect Dis Rep, 2021, 23(3): 3. doi: 10.1007/s11908-021-00746-1
[20]	BURNS J C, GLODÁ M P. Kawasaki syndrome[J]. Lancet, 2004, 364(9433): 533-544. doi: 10.1016/S0140-6736(04)16814-1
[21]	ORENSTEIN J M, SHULMAN S T, FOX L M, et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study[J]. PLoS One, 2012, 7(6): e38998. doi: 10.1371/journal.pone.0038998
[22]	YUTANI C, OKANO K, KAMIYA T, et al. Histopathological study on right endomyocardial biopsy of Kawasaki disease[J]. Br Heart J, 1980, 43(5): 589-592. doi: 10.1136/hrt.43.5.589
[23]	DAHDAH N. Not just coronary arteritis, Kawasaki disease is a myocarditis, too[J]. J Am Coll Cardiol, 2010, 55(14): 1507-1508.
[24]	YUTANI C, GO S, KAMIYA T, et al. Cardiac biopsy of Kawasaki disease[J]. Arch Pathol Lab Med, 1981, 105(9): 470-473.
[25]	FUJIWARA H, HAMASHIMA Y. Pathology of the heart in Kawasaki disease[J]. Pediatrics, 1978, 61(1): 100-107. doi: 10.1542/peds.61.1.100
[26]	DIONNE A, DAHDAH N. Myocarditis and Kawasaki disease[J]. Int J Rheum Dis, 2018, 21(1): 45-49. doi: 10.1111/1756-185X.13219
[27]	JINDAL A K, PILANIA R K, PRITHVI A, et al. Kawasaki disease: characteristics, diagnosis, and unusual presentations[J]. Expert Rev Clin Immunol, 2019, 15(10): 1089-1104. doi: 10.1080/1744666X.2019.1659726
[28]	WELISCH E, NOROZI K, RAUCH R. N-terminal pro-brain natriuretic peptide level as a screening tool for cardiac involvement in paediatric diseases of extracardiac origin[J]. Clin Res Cardiol, 2011, 100(9): 723-730. doi: 10.1007/s00392-011-0317-0
[29]	REDDY M, SINGH S, RAWAT A, et al. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease[J]. Rheumatol Int, 2016, 36(4): 551-559. doi: 10.1007/s00296-016-3430-6
[30]	狄亚珍, 吴菱, 钟世玲, 等. 血N末端脑利钠肽原及高密度脂蛋白胆固醇对川崎病心血管损害预测价值的研究[J]. 中华风湿病学杂志, 2014, 18(3): 170-175.
[31]	SERGEEVA I A, CHRISTOFFELS V M. Regulation of expression of atrial and brain natriuretic peptide, biomarkers for heart development and disease[J]. Biochim Biophys Acta, 2013, 1832(12): 2403-2413. doi: 10.1016/j.bbadis.2013.07.003
[32]	MORAES J C B, RIBEIRO A C M, SAAD C G S, et al. NT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study[J]. Clin Rheumatol, 2013, 32(6): 879-883. doi: 10.1007/s10067-013-2182-x
[33]	YANAGISAWA D, AYUSAWA M, KATO M, et al. Factors affecting N-terminal pro-brain natriuretic peptide elevation in the acute phase of Kawasaki disease[J]. Pediatr Int, 2016, 58(11): 1105-1111. doi: 10.1111/ped.12986

[1]	ZOU Yingcai, ZHOU Li, WANG Jiangning, GAO Lei. Effects of antibiotic-loaded bone cement coverage versus negative pressure wound therapy on diabetic foot ulcer wound healing[J]. Journal of Clinical Medicine in Practice, 2024, 28(23): 105-109, 115. DOI: 10.7619/jcmp.20243314
[2]	MA Nan, QI Ying, LI Junpeng, LIU Luyao, YANG Lixin. Correlations of blood lipid levels with lesion area and severity in patients with psoriasis vulgaris in high-altitude areas[J]. Journal of Clinical Medicine in Practice, 2024, 28(16): 70-73, 82. DOI: 10.7619/jcmp.20241613
[3]	MA Zheng, ZHANG Guoyong, LIU Peilin, LIAN Zheng, GUO Caixia. Correlations of brachial-ankle pulse wave conduction velocity, ankle-brachial index and dynamic arterial stiffness index with left ventricular diastole in coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2023, 27(16): 57-62. DOI: 10.7619/jcmp.20231850
[4]	CHENG Mei, FANG Zhaohui, CHENG Ruodong, QIAO Lulu. Effect of ultrasonic debridement combined with traditional Chinese medicine foot bath on Wagner grade 2 and 3 ulcer of diabetic foot[J]. Journal of Clinical Medicine in Practice, 2022, 26(17): 116-119. DOI: 10.7619/jcmp.20221212
[5]	XU Yongcheng, WANG Jia. Value of peripheral vascular stent intervention in treatment of diabetic patients with arteriosclerosis obliterans of lower limbs complicating foot gangrene[J]. Journal of Clinical Medicine in Practice, 2020, 24(13): 20-22. DOI: 10.7619/jcmp.202013006
[6]	ZHOU Yonghui. Nursing observation of VSD vacuum aspiration combined with inner fixation in treating large area avulsion of the lower limbs[J]. Journal of Clinical Medicine in Practice, 2015, (4): 79-81. DOI: 10.7619/jcmp.201504025
[7]	XU Lamei. Nursing for patients with granulation edema of wound by treatment of modified vacuum aspiration dressing[J]. Journal of Clinical Medicine in Practice, 2013, (22): 59-61. DOI: 10.7619/jcmp.201322021
[8]	HU Qu, LIU Jiao, HAN Limin. Importance of ankle-brachial pressure index in the diagnosis of coronary artery disease in women with diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2013, (21): 87-90. DOI: 10.7619/jcmp.201321024
[9]	ZHAO Xiaoxi, XU Rixin, HE Shenghu, MA Bingbing, DENG Min. Predictive value of ankle brachial index to renal microvascular complications in elderly hypertensive patients[J]. Journal of Clinical Medicine in Practice, 2013, (11): 113-115. DOI: 10.7619/jcmp.201311045
[10]	ZOU Li. The clinical significance of ankle-brachial index in diagnosing lower extremity artery disease in diabetic patients[J]. Journal of Clinical Medicine in Practice, 2011, (17): 37-39. DOI: 10.3969/j.issn.1672-2353.2011.17.012

Cited By

Cited by

Periodical cited type(3)

1.	廖飞飞，杨文文，路爱梅，曲华，王洁，龙霖梓，付长庚. 麝香通心滴丸调控HIF-1α/HO-1通路抑制铁死亡缓解心肌缺血再灌注损伤研究. 陕西中医. 2025(02): 147-152+158 .
2.	黄兴，寇冠军，范立华，张志国. 麝香通心滴丸的临床研究进展. 中医研究. 2024(09): 92-96 .
3.	郑文辉，吴瑞华. 麝香通心滴丸治疗微血管性心绞痛的疗效及临床安全性. 中国卫生标准管理. 2024(21): 160-163+168 .

Other cited types(1)

Get Citation

PDF

XML

Article views (139) PDF downloads (21) Cited by(4)

Turn off MathJax

Article Contents

Abstract

References

Value of human cartilage glycoprotein-39 and N-terminal prohormone of brain natriuretic peptide in coronary artery injury in children with Kawasaki disease

Abstract

References

Related Articles

Cited by

Periodical cited type(3)

Other cited types(1)

Catalog

Value of human cartilage glycoprotein-39 and N-terminal prohormone of brain natriuretic peptide in coronary artery injury in children with Kawasaki disease

Abstract

References

Related Articles

Cited by

Periodical cited type(3)

Other cited types(1)

Catalog

Export File

Citation

Format

Content